Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of BGM0504 in Overweight or Obese Participants
Sponsor: BrightGene Bio-Medical Technology Co., Ltd.
Summary
The purpose of the study is to evaluate the influence of BGM0504 injection on gastric emptying and Pharmacokinetics of metformin and warfarin in overweight or obese participants
Official title: A Single Center, Open-label, Fixed Sequence Trial, Investigating the Influence of BGM0504 Injection on Gastric Emptying and Pharmacokinetics of Metformin and Warfarin in Overweight or Obese Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-03-25
Completion Date
2025-07-25
Last Updated
2026-10-13
Healthy Volunteers
No
Conditions
Interventions
Paracetamol
oral, postprandial
Metformin Hydrochloride
Oral , Fasting
Warfarin
Oral , Fasting
BGM0504
Administered SC
Locations (1)
The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine)
Kunming, Yunnan, China